Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

Why do we need Active Surveillance? The problem of overdiagnosis, indolent cancer and overtreatment

07 Oct 2016

Active Surveillance for low risk prostate cancer. Session proposed by ESO

Monique Roobol

M. Roobol

Resources

Reserved to ESMO members

Watch the webcast View the presentation

07 Oct 2016

Presenter: Anders Bjartell

Session: Active Surveillance for low risk prostate cancer. Session proposed by ESO

Resources:

Presentation

Webcast

07 Oct 2016

Presenter: Lara Bellardita

Session: Active Surveillance for low risk prostate cancer. Session proposed by ESO

Resources:

Presentation

Webcast